Press release
Thyroid Cancer Market: Pipeline Review, H2 2022
HTF Market Intelligence released a new research report of 885 pages on title 'Thyroid Cancer - Pipeline Review, H2 2022' with detailed analysis, forecast and strategies. The market Study is segmented by key a region that is accelerating the marketization. The study is a perfect mix of qualitative and quantitative Market data collected and validated majorly through primary data and secondary sources. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones.Download Sample Report PDF >>> https://www.htfmarketreport.com/sample-report/1014908-thyroid-cancer-pipeline-review-2
Thyroid Cancer - Pipeline Review, H2 2022
Thyroid cancer is a cancer that starts in the thyroid gland. Symptoms include lump that can be felt through the skin on neck, difficulty swallowing, pain in neck and throat and swollen lymph nodes in neck. Predisposing factors include female, high levels of radiation and inherited genetic syndromes. Treatment includes surgery and thyroid hormone therapy.
Report Highlights:
HTF MI'S Pharmaceutical and Healthcare latest pipeline guide Thyroid Cancer - Pipeline Review, H2 2022, provides comprehensive information on the therapeutics under development for Thyroid Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Thyroid Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Thyroid Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 5, 37, 33, 3, 20, 2 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 6 and 2 molecules, respectively.
Thyroid Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from HTF MI'S proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope:
- The pipeline guide provides a snapshot of the global therapeutic landscape of Thyroid Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Thyroid Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Thyroid Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Thyroid Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Thyroid Cancer (Oncology)
Reasons to Buy:
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Thyroid Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Thyroid Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Companies Mentioned in the Report:
ABM Therapeutics Inc
Advanced Accelerator Applications SA
Advenchen Laboratories LLC
AffyImmune Therapeutics Inc
Aslan Pharmaceuticals Ltd
AstraZeneca Plc
Bayer AG
BeiGene Ltd
BioMed Valley Discoveries Inc
Biovista Inc
Blueprint Medicines Corp
BNOAT Oncology Inc
Boehringer Ingelheim International GmbH
Boston Pharmaceuticals Inc
Bristol-Myers Squibb Co
CAS-Lamvac Biotech Co Ltd
Celldex Therapeutics Inc
Cello Therapeutics Inc
Centrose LLC
CSPC Pharmaceutical Group Ltd
CytImmune Sciences Inc
Daiichi Sankyo Co Ltd
Debiopharm International SA
Ecrins Therapeutics SAS
Eisai Co Ltd
Eli Lilly and Co
Exelixis Inc
F. Hoffmann-La Roche Ltd
Genelux Corp
Genmab AS
Gradalis Inc
Hutchison MediPharma Ltd
ImmunityBio Inc
ImmunoForge Co Ltd
Immunomedics Inc
IngenoVax LLC
Innovative Cellular Therapeutics Co Ltd
Intensity Therapeutics Inc
Jiangsu Hengrui Medicine Co Ltd
Johnson & Johnson
Kemimedi Co Ltd
Kitov Pharma Ltd
Konruns Pharmaceutical Co Ltd
Lotus Pharmaceutical Co Ltd
Loxo Oncology Inc
MacroGenics Inc
MaxiVAX SA
Merck & Co Inc
Mersana Therapeutics Inc
Millennium Pharmaceuticals Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Pfizer Inc
Plexxikon Inc
Plus Therapeutics Inc
PRISM Pharma Co Ltd
QED Therapeutics Inc
Recordati SpA
Regeneron Pharmaceuticals Inc
Rodos BioTarget GmbH
Savoy Pharmaceuticals Inc
Sino Biopharmaceutical Ltd
Sotio AS
SpringWorks Therapeutics Inc
Suzhou SmartNuclide Biopharmaceutical Co Ltd
Suzhou Zelgen Biopharmaceutical Co Ltd
Synactix Pharmaceuticals Inc
Tarveda Therapeutics Inc
Trophogen Inc
Turning Point Therapeutics Inc
Tyme Technologies Inc
UBI Pharma Inc
UbiVac LLC
Vaccinex Inc
Vascular Biogenics Ltd
Veana Therapeutics LLC
Xiangxue Life Sciences
Xspray Pharma AB
Xynomic Pharmaceuticals Holdings Inc
Zhengda Tianqing Kangfang Shanghai Biomedical Technology Co Ltd
....Continued
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia Pacific.
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=1014908
Contact US:
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA - 08837
Phone: +1 (434) 299-0043
sales@htfmarketreport.com
Connect with us at LinkedIn | Facebook | Twitter
About Author:
HTF Market Intelligence consulting is uniquely positioned empower and inspire with research and consulting services to empower businesses with growth strategies, by offering services with extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist in decision making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thyroid Cancer Market: Pipeline Review, H2 2022 here
News-ID: 2766282 • Views: …
More Releases from HTF Market Intelligence Consulting Private Limited
Linen Fabric Market Hits New High | Major Giants LinenMe, Libeco, H&M
HTF MI just released the Global Linen Fabric Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
LinenMe, Libeco, H&M, IKEA, Towels, Ralph…
Hosiery Market Hits New High | Major Giants Jockey, Fruit of the Loom, Peds
HTF MI just released the Global Hosiery Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
Hanesbrands, Calvin Klein, Nike, Adidas, L'eggs, Burlington,…
Aquaculture Market Is Going to Boom| Regal Springs, AquaStar, Best Aquaculture P …
HTF MI just released the Global Aquaculture Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
Marine Harvest, Thai Union Group, Mowi, Leroy…
C5ISR Market Is Booming So Rapidly Major Giants | Viasat, Textron
HTF MI just released the Global C5ISR Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
Lockheed Martin, Northrop Grumman, Raytheon Technologies, General…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
